{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T19:31:29Z","timestamp":1779132689316,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>People involved with the criminal justice system typically have lower healthcare engagement and higher risk of hepatitis C virus (HCV) infection than the general population. Interventions run at community corrections centres have the potential to diagnose and treat previously unreached populations. This study aimed to estimate the cost per treatment initiation and cost per cure through HCV programs at community corrections centres.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were obtained over the period of July 2022 to July 2023 from screening clinics run by Hepatitis Queensland in four community corrections centres located in Brisbane, Australia. All non-drugcosts (presented in 2023 A$ without discounting) were included from the perspective of the clinics, including staff salaries, general practitioner (GP) fees, logistics, medical testing, incentives and overhead costs. Costs of follow up instances were estimated from total nurse follow-up time per clinic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The total non-drug cost accumulated over 33 clinics in the 13-month study period was $159,982. Among the 185 participants, 23 tested RNA positive (12%). At the end of the study period 8 participants had achieved sustained virologic response (SVR) and 6 were still on treatment. This resulted in a cost per cure of $19,998 or $11,427 per patient initiated on treatment. If GP costs were excluded (i.e. paid by Medicare and not the clinic) the cost per cure and cost per treatment initiation were $12,843 and $7,339 respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>As overall prevalence decreases and case finding becomes a greater challenge, providing HCV testing and treatment through community correctional centres may be a cost-effective way of reaching people living with HCV not engaged with healthcare.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12913-025-13664-y","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T12:07:14Z","timestamp":1766146034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Costing analysis of a Queensland community corrections hepatitis C screening program"],"prefix":"10.1186","volume":"25","author":[{"given":"Kelly","family":"Maynard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah","family":"Houdroge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna L.","family":"Hawkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisa","family":"Pedrana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline A.","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"13664_CR1","volume-title":"Global health sector strategy on viral hepatitis 2016-2021","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. 2016."},{"key":"13664_CR2","unstructured":"King J, McManus H, Kwon J, Gray R, McGregor S. HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2023. 2023. UNSW Sydney: Kirby Institute."},{"key":"13664_CR3","doi-asserted-by":"crossref","unstructured":"Papaluca T, Thompson A. HCV elimination: breaking down the barriers to prison based care. Hepatoma Res. 2018;4(64).","DOI":"10.20517\/2394-5079.2018.53"},{"key":"13664_CR4","doi-asserted-by":"crossref","unstructured":"Winter RJ, Holmes JA, Papaluca TJ, Thompson AJ. The importance of prisons in achieving hepatitis C elimination: insights from the Australian experience. Viruses. 2022;14(3).","DOI":"10.3390\/v14030497"},{"issue":"2","key":"13664_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1360-0443.2006.01316.x","volume":"101","author":"S Fazel","year":"2006","unstructured":"Fazel S, Bains P, Doll H. Substance abuse and dependence in prisoners: a systematic review. Addiction. 2006;101(2):181\u201391..","journal-title":"Addiction"},{"key":"13664_CR6","volume-title":"The health of Australia\u2019s prisoners 2018","author":"Australian Institute of Health and Welfare","year":"2019","unstructured":"Australian Institute of Health and Welfare. The health of Australia\u2019s prisoners 2018. Canberra: AIHW; 2019."},{"key":"13664_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.drugpo.2017.12.013","volume":"54","author":"EB Cunningham","year":"2018","unstructured":"Cunningham EB, Hajarizadeh B, Amin J, Bretana N, Dore GJ, Degenhardt L, et al. Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: the HITS-p study. Int J Drug Policy. 2018;54:18\u201325..","journal-title":"Int J Drug Policy"},{"issue":"3","key":"13664_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/dar.12881","volume":"38","author":"RJ Winter","year":"2019","unstructured":"Winter RJ, Stoove M, Agius PA, Hellard ME, Kinner SA. Injecting drug use is an independent risk factor for reincarceration after release from prison: a prospective cohort study. Drug Alcohol Rev. 2019;38(3):254\u201363.","journal-title":"Drug Alcohol Rev"},{"key":"13664_CR9","unstructured":"Burnet Institute, Kirby Institute. Australia\u2019s progress towards hepatitis C elimination: annual report 2024. 2024. Melbourne: Burnet Institute."},{"issue":"11","key":"13664_CR10","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S1473-3099(19)30536-5","volume":"19","author":"TJ Papaluca","year":"2019","unstructured":"Papaluca TJ, Tambakis G, Iser D, Thompson AJ. Effective prison-based treatment and linkage to care after release. Lancet Infect Dis. 2019;19(11):1171.","journal-title":"Lancet Infect Dis"},{"key":"13664_CR11","unstructured":"Australian Bureau of Statistics. Corrective services, Australia: ABS; Dec-quarter-2023. Available from: https:\/\/www.abs.gov.au\/statistics\/people\/crime-and-justice\/corrective-services-australia\/latest-release. Accessed 6 May 2024."},{"key":"13664_CR12","doi-asserted-by":"publisher","first-page":"102548","DOI":"10.1016\/j.eclinm.2024.102548","volume":"70","author":"RJ Winter","year":"2024","unstructured":"Winter RJ, Griffin S, Sheehan Y, Nguyen W, Stoove M, Lloyd AR, et al. People in community corrections are a population with unmet need for viral hepatitis care. EClinicalMedicine. 2024;70:102548.","journal-title":"EClinicalMedicine"},{"key":"13664_CR13","unstructured":"Selvey LA, Carpenter M, Nguyen W, Thompson R, Hawkes AL. Hepatitis C testing and treatment in community corrections centres in Brisbane, Australia. 2025."},{"issue":"11","key":"13664_CR14","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1111\/jvh.13596","volume":"28","author":"AY Palmer","year":"2021","unstructured":"Palmer AY, Chan K, Gold J, Layton C, Elsum I, Hellard M, et al. A modelling analysis of financial incentives for hepatitis C testing and treatment uptake delivered through a community-based testing campaign. J Viral Hepat. 2021;28(11):1624\u201334.","journal-title":"J Viral Hepat"},{"key":"13664_CR15","unstructured":"Australian Government, Productivity Commission. Report on Government Services. Justice - Report on Government Services 2025. Justice sector overview. Table CA.4: adults released from prison who returned to prison or to corrective services with a new correctional sanction within two years. 2025. Accessed 25 Sept 2025. https:\/\/www.pc.gov.au\/ongoing\/report-on-government-services\/2025\/data-downloads"},{"issue":"10","key":"13664_CR16","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1093\/cid\/ciac246","volume":"75","author":"JM Carson","year":"2022","unstructured":"Carson JM, Dore GJ, Lloyd AR, Grebely J, Byrne M, Cunningham E, et al. Hepatitis C virus reinfection following direct-acting antiviral treatment in the prison setting: the SToP-C study. Clin Infect Dis. 2022;75(10):1809\u201319.","journal-title":"Clin Infect Dis"},{"key":"13664_CR17","unstructured":"Somoray K, Jeffs S. Baseline report: the sentencing of people in Queensland. 2021. Queensland, Australia: Queensland Sentencing Advisory Council."},{"key":"13664_CR18","volume-title":"Combined orders of imprisonment with a community correction order in Victoria","author":"P McGorrery","year":"2023","unstructured":"McGorrery P, Schollum P. Combined orders of imprisonment with a community correction order in Victoria. Melbourne, Victoria, Australia: Sentencing Advisory Council; 2023."},{"issue":"4","key":"13664_CR19","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/jgh.13223","volume":"31","author":"N Scott","year":"2016","unstructured":"Scott N, Iser DM, Thompson AJ, Doyle JS, Hellard ME. Cost-effectiveness of treating chronic hepatitis C virus with direct-acting antivirals in people who inject drugs in Australia. J Gastroenterol Hepatol. 2016;31(4):872\u201382.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"13664_CR20","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/hep.26431","volume":"58","author":"NK Martin","year":"2013","unstructured":"Martin NK, Vickerman P, Grebely J, Hellard M, Hutchinson SJ, Lima VD, et al. Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals. Hepatology. 2013;58(5):1598\u2013609.","journal-title":"Hepatology"},{"key":"13664_CR21","volume-title":"The health of people in Australia\u2019s prisons 2022, catalogue number PHE 334","author":"Australian Institute of Health and Welfare","year":"2023","unstructured":"Australian Institute of Health and Welfare. The health of people in Australia\u2019s prisons 2022, catalogue number PHE 334. Australian Government: AIHW; 2023."},{"issue":"8","key":"13664_CR22","doi-asserted-by":"publisher","first-page":"ofac350","DOI":"10.1093\/ofid\/ofac350","volume":"9","author":"T Papaluca","year":"2022","unstructured":"Papaluca T, Craigie A, McDonald L, Edwards A, Winter R, Hoang A, et al. Care navigation increases initiation of hepatitis C treatment after release from prison in a prospective randomized controlled trial: the C-LINK study. Open Forum Infect Dis. 2022;9(8):ofac350.","journal-title":"Open Forum Infect Dis"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13664-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-13664-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13664-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T12:07:16Z","timestamp":1766146036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-025-13664-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13664"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-13664-y","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"8 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was carried out in compliance with the Helsinki Declaration. Aggregate epidemiological data was used from a pilot program published elsewhere. The original pilot program data was approved by The University of Queensland Human Research Ethics Committee (approval number 20200000309). Research was undertaken with informed consent of all participants. Costing data only used aggregate costing information not related to individuals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1606"}}